Delivery Order SPE2DB20D3505-SPE2DB25FYCPM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,219.02 to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (150 mL) with a firm fixed price structure. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and represents a non-competitive, direct fulfillment against an existing contract vehicle. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (150 mL) with a firm fixed price ceiling value of $1,332.16. This non-set-aside competitive award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300 mL quantity, with a firm fixed price ceiling value of $1,427.88. This non-competitive delivery order, which has an ultimate completion date of September 11, 2025, falls under the Medical Supply Chain division of the Department of Defense. The award represents a child contract...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract worth $9,294.58 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a specialty pharmaceutical product, with a ceiling value of $4,541.10 and a period of performance through May 20, 2024. The contract does not have a set-aside designation, indicating it was an open competition....
- The Defense Logistics Agency awarded a $4,743 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561566552 KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for oral suspension medication to be delivered between July 21-24, 2023 under an existing DLA contract vehicle. As the DLA supports military readiness through logistics solutions, this order will likely provide needed...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,393.65, is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The order is for the supply of 300 ml oral suspension of the drug KONVOMEP 2-84 mg/ml, with a ceiling value of $6,729.12 and a period of performance through April 9, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,530.00 order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The order has a completion date of January 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,530.00, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen Drug Corp is a for-profit organization that holds several Indefinite...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCPMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (300mL) with a ceiling value of $1,154.53. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The delivery order is executed under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates the company's capability to fulfill federal procurement requirements for specialized medications across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |